Modelling the population cost-effectiveness of current and evidence-based optimal treatment for anxiety disorders

2004 ◽  
Vol 34 (1) ◽  
pp. 19-35 ◽  
Author(s):  
C. ISSAKIDIS ◽  
K. SANDERSON ◽  
J. CORRY ◽  
G. ANDREWS ◽  
H. LAPSLEY

Background. The present paper describes a component of a large population cost-effectiveness study that aimed to identify the averted burden and economic efficiency of current and optimal treatment for the major mental disorders. This paper reports on the findings for the anxiety disorders (panic disorder/agoraphobia, social phobia, generalized anxiety disorder, post-traumatic stress disorder and obsessive–compulsive disorder).Method. Outcome was calculated as averted ‘years lived with disability’ (YLD), a population summary measure of disability burden. Costs were the direct health care costs in 1997–8 Australian dollars. The cost per YLD averted (efficiency) was calculated for those already in contact with the health system for a mental health problem (current care) and for a hypothetical optimal care package of evidence-based treatment for this same group. Data sources included the Australian National Survey of Mental Health and Well-being and published treatment effects and unit costs.Results. Current coverage was around 40% for most disorders with the exception of social phobia at 21%. Receipt of interventions consistent with evidence-based care ranged from 32% of those in contact with services for social phobia to 64% for post-traumatic stress disorder. The cost of this care was estimated at $400 million, resulting in a cost per YLD averted ranging from $7761 for generalized anxiety disorder to $34 389 for panic/agoraphobia. Under optimal care, costs remained similar but health gains were increased substantially, reducing the cost per YLD to <$20 000 for all disorders.Conclusions. Evidence-based care for anxiety disorders would produce greater population health gain at a similar cost to that of current care, resulting in a substantial increase in the cost-effectiveness of treatment.

2020 ◽  
Vol 8 (18) ◽  

The purpose of this review study is to examine the psychological effects of the COVID-19 outbreak on individuals in different groups. When the literature is examined, it can be stated that this epidemic causes negative emotional reactions such as anxiety, fear, and anger in adults, increases stress levels, increases their susceptibility to psychological disorders such as anxiety disorders, depressive disorders, posttraumatic stress disorder, and causes suicidal thoughts and insomnia. It can be stated that fear and anxiety are experienced intensely in children and adolescents, anxiety disorders increase, and their parents need to make explanations appropriate to their children's cognitive levels to prevent these disorders. It is indicated that health workers struggling with the epidemic on the field have symptoms related to anxiety disorders, post-traumatic stress disorder, and depressive disorders. They experience sleep disorders and their effective problem-solving skills decrease due to the stress and conflicts they experience. In the light of this information, it can be thought that it is important that health authorities and the media emphasize issues such as raising awareness about symptoms related to psychological disorders, activities that support psychological health, and the importance of receiving psychological support when necessary. In the last part of the study, it was aimed to make suggestions for future research about pandemic related psychological disorders in our country. In this context, it has been suggested that studies can be carried out related to exposure to traumatic contents in the media, curfew, how being in certain age groups affect individuals, the effectiveness of primary and secondary prevention interventions and various psychological interventions, and the effective use of social support mechanisms in the pandemic process. Keywords COVID-19, psychological effects, psychological disorders, clinical psychology, post traumatic stress disorder


2020 ◽  
Vol 30 (2) ◽  
pp. 112-128
Author(s):  
Georgina du Mello Kenyon ◽  
Jim Schirmer

AbstractThe prevalence of post-traumatic stress disorder symptoms in children and adolescents requires school psychologists and counsellors to be informed of evidence-based elements of interventions through which they can tailor their treatment to the individual in a school context. This meta-analysis identified common practice elements within evidence-based trauma interventions for schools. A small to medium effect size was identified in the 10 randomised controlled trials (RCTs) included in this meta-analysis. Within these RCTs, 31 common practice elements were identified, with social skills training, coping skills training, relaxation techniques, psychoeducation, mind-body techniques, group work and creative-expressive techniques correlating with the most effective outcomes. The findings suggest that common practice elements exist across multiple school-based trauma interventions of varying modalities.


2019 ◽  
Vol 15 (2) ◽  
pp. 116-131
Author(s):  
Stephanie Laird ◽  
Luke J. Ney ◽  
Kim L. Felmingham ◽  
Andrea Gogos

Background: The combined oral contraceptive pill (OC), containing synthetic estrogens and progestins, is used by millions of women worldwide, yet little is known about its effects on cognition or on psychiatric disorders. The progestin component of OCs determines their androgenicity, i.e. whether the OC has androgen binding components with masculinising effects or antiandrogenic components with feminising effects. Objective: The present review discusses the literature surrounding OC use and cognition in healthy women. Given the important role that sex hormones play in psychiatric disorders, we also consider the influence of OCs on symptoms of schizophrenia, post-traumatic stress disorder, depression, bipolar disorder, anxiety disorders and indirectly, sleep quality. Results: Research has shown that while there are no differences between OC users and non-users, androgenic OCs enhance visuospatial ability and anti-androgenic OCs enhance verbal fluency. Little is known about OCs effects on other cognitive domains, such as memory and executive function. There is little research examining OC use in schizophrenia, post-traumatic stress disorder, bipolar disorder and anxiety disorders. There is some evidence that OC use is associated with depression, however the exact causality of this association remains to be verified. Conclusion: We maintain that future studies need to address several methodological limitations, such as separating OCs based on androgenicity to avoid the masking effects that occur when various OCs are considered as one group. As this review highlights several significant effects of OC use on the brain, the implications of OC use needs to be considered in future research.


2013 ◽  
Vol 19 (3) ◽  
pp. 5 ◽  
Author(s):  
S Seedat

<div style="left: 70.8662px; top: 324.72px; font-size: 15.45px; font-family: serif; transform: scaleX(1.01119);" data-canvas-width="421.07550000000003">Post-traumatic stress disorder (PTSD) is among the most prevalent</div><div style="left: 70.8662px; top: 344.72px; font-size: 15.45px; font-family: serif; transform: scaleX(0.979077);" data-canvas-width="419.514">anxiety disorders, both in terms of lifetime and 12-month prevalence</div>rates documented in epidemiological studies worldwide.


Sign in / Sign up

Export Citation Format

Share Document